{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:10:38Z","timestamp":1775617838783,"version":"3.50.1"},"reference-count":65,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomimetics"],"abstract":"<jats:p>Past published studies have already documented that, subsequent to the intravenous injection of colloidal lipid nanocarriers, apolipoprotein (apo)A-I is adsorbed from the blood onto the nanoparticle surface. The adsorbed apoA-I mediates the interaction of the nanoparticle with scavenger receptors on the blood\u2013brain barrier (BBB), followed by receptor-mediated endocytosis and subsequent transcytosis across the BBB. By incorporating the appropriate drug(s) into biomimetic (lipid cubic phase) nanocarriers, one obtains a multitasking combination therapeutic which targets certain cell-surface scavenger receptors, mainly class B type I (i.e., SR-BI), and crosses the BBB. Documented similarities in lipid composition between naturally occurring high-density lipoproteins (HDL) and the artificial biomimetic (nanoemulsion) nanocarrier particles can partially simulate or mimic the known heterogeneity (i.e., subpopulations or subspecies) of HDL particles. Such biomedical application of colloidal drug-nanocarriers can potentially be extended to the treatment of complex medical disorders like dementia. The risk factors for dementia trigger widespread inflammation and oxidative stress; these two processes involve pathophysiological cascades which lead to neuronal Ca2+ increase, neurodegeneration, gradual cognitive\/memory decline, and eventually (late-onset) dementia. In particular, more recent research indicates that chronic inflammatory stimulus in the gut may induce (e.g., via serum amyloid A (SAA)) the release of proinflammatory cytokines. Hence, an effective preventive and therapeutic strategy could be based upon drug targeting toward a major SAA receptor responsible for the SAA-mediated cell signaling events leading to cognitive decline and eventually Alzheimer\u2019s disease or (late-onset) dementia.<\/jats:p>","DOI":"10.3390\/biomimetics5010011","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T07:29:07Z","timestamp":1584689347000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2779-283X","authenticated-orcid":false,"given":"Joseph","family":"D\u2019Arrigo","sequence":"first","affiliation":[{"name":"Cavitation-Control Technology Inc., Farmington, CT 06032, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"ref_1","first-page":"29","article-title":"Alzheimer\u2019s disease, brain injury, and CNS nanotherapy in humans: Sonoporation augmenting drug targeting","volume":"5","year":"2017","journal-title":"Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cis.2017.12.002","article-title":"Nanotherapy for Alzheimer\u2019s disease and vascular dementia: Targeting senile endothelium","volume":"251","year":"2018","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Daulatzai, M.A. (2016). Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer\u2019s disease. J. Neurosci. Res.","DOI":"10.1002\/jnr.23777"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2016.01.014","article-title":"Role of scavenger receptors in peptide-based delivery of plasmid DNA across a blood\u2013brain barrier model","volume":"500","author":"Srimanee","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nbd.2015.08.014","article-title":"Vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease \u2014 a review of endothelium-mediated mechanisms and ensuing vicious circles","volume":"82","author":"Venneri","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/bs.irn.2016.06.002","article-title":"Application of nanomedicine to the CNS diseases","volume":"130","author":"Carradori","year":"2016","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood\u2013brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3233\/JAD-151179","article-title":"High-throughput screening for identification of blood\u2013brain barrier integrity enhancers: A drug repurposing opportunity to rectify vascular amyloid toxicity","volume":"53","author":"Qosa","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10571-015-0256-9","article-title":"Endothelial dysfunction and amyloid-induced neurovascular alterations","volume":"36","author":"Koizumi","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3233\/JAD-160284","article-title":"Breakdown of the cerebrovasculature and blood\u2013brain barrier: A mechanistic link between diabetes mellitus and Alzheimer\u2019s disease","volume":"54","author":"Goldwaser","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1166\/jns.2012.1012","article-title":"Overcoming the blood brain barrier: The challenge of brain drug targeting","volume":"2","author":"Mahringer","year":"2012","journal-title":"J. Nanoneurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3389\/fphys.2017.00841","article-title":"SR-BI mediated transcytosis of HDL in brain microvascular endothelial cells is independent of caveolin, clathrin, and PDZK1","volume":"8","author":"Fung","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13024-017-0201-0","article-title":"High-density lipoproteins suppress A\u03b2-induced PBMC adhesion to human endothelial cells in bioengineered vessels and in monoculture","volume":"12","author":"Robert","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bbadis.2015.10.005","article-title":"Reconstituted high-density lipoproteins acutely reduce soluble brain A\u03b2 levels in symptomatic APP\/PS1 mice","volume":"1862","author":"Robert","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","article-title":"HDL and cognition in neurodegenerative disorders","volume":"72","author":"Hottman","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.1523\/JNEUROSCI.1762-16.2016","article-title":"Reduced efficacy of anti-A immunotherapy in a mouse model of amyloid deposition and vascular cognitive impairment comorbidity","volume":"36","author":"Weekman","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","article-title":"Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease","volume":"1862","author":"Nelson","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbadis.2015.12.023","article-title":"Vascular contributions to cognitive impairment, clinical Alzheimer\u2019s disease, and dementia in older persons","volume":"1862","author":"Kapasi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"McAleese, K.L., Alafuzoff, I., Charidimou, A., De Reuck, J., Grinberg, L.T., Hainsworth, A.H., Hortobagyi, T., Ince, P., Jellinger, K., and Gao, J. (2016). Post-mortem assessment in vascular dementia: Advances and aspirations. BMC Med., 14.","DOI":"10.1186\/s12916-016-0676-5"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3233\/JAD-150832","article-title":"The role of cerebrovascular disease in amyloid deposition","volume":"54","author":"Noh","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ene.12845","article-title":"Cognitive and affective functions in Alzheimer\u2019s disease patients with metabolic syndrome","volume":"23","author":"Hishikawa","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/WNL.0000000000002590","article-title":"Brain arterial aging and its relationship to Alzheimer dementia","volume":"86","author":"Gutierrez","year":"2016","journal-title":"Neurology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.arr.2016.06.001","article-title":"Cerebral circulation in aging","volume":"30","author":"Nagata","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/jnr.23925","article-title":"Major pathogenic mechanisms in vascular dementia: Roles of cellular stress response and hormesis in neuroprotection","volume":"94","author":"Calabrese","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00581.2016","article-title":"Functional vascular contributions to cognitive impairment and dementia: Mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging","volume":"312","author":"Toth","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/0271678X15606463","article-title":"BACE-1 is expressed in the blood\u2013brain barrier endothelium and is upregulated in a murine model of Alzheimer\u2019s disease","volume":"36","author":"Devraj","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/cns.12503","article-title":"Hyperglycemia increases the production of amyloid-peptide leading to decreased endothelial tight junction","volume":"22","author":"Chao","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11481-017-9752-7","article-title":"Blood-brain barrier injury in diabetes: Unrecognized effects on brain and cognition","volume":"12","author":"Boguch","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12974-016-0670-z","article-title":"HGMB1 and thrombin mediate the blood\u2013brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease","volume":"13","author":"Festoff","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/01.hjh.0000491393.79855.fc","article-title":"Pulsatile stretch alters expression and processing of amyloid precursor protein in human cerebral endothelial cells","volume":"34","author":"Gangoda","year":"2016","journal-title":"J. Hypertens."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e12953","DOI":"10.14814\/phy2.12953","article-title":"Increased pulmonary arteriolar tone associated with lung oxidative stress and nitric oxide in a mouse model of Alzheimer\u2019s disease","volume":"4","author":"Roberts","year":"2016","journal-title":"Physiol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kyrtsos, C.R., and Baras, J.S. (2015). Modeling the role of the glymphatic pathway and cerebral blood vessel properties in Alzheimer\u2019s disease pathogenesis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139574"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","article-title":"Stroke injury, cognitive impairment and vascular dementia","volume":"1862","author":"Kalaria","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0891988716654987","article-title":"Update on vascular dementia","volume":"29","author":"Khan","year":"2016","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jphs.2016.07.001","article-title":"Cigarette smoking impairs nitric oxide-mediated cerebral blood flow increase: Implications for Alzheimer\u2019s disease","volume":"131","author":"Toda","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ajh\/hpv122","article-title":"Endothelial activation is associated with cognitive performance in patients with hypertension","volume":"29","author":"Uiterwijk","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrneurol.2014.44","article-title":"Lessons from immunotherapy for Alzheimer\u2019s disease","volume":"10","author":"Wang","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","article-title":"Deciphering the mechanism underlying late-onset Alzheimer\u2019s disease","volume":"9","author":"Krstic","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"ref_39","unstructured":"D\u2019Arrigo, J.S. (2011). Stable Nanoemulsions: Self-Assembly in Nature and Nanomedicine, Elsevier."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01054766","article-title":"Internalization of microbubbles by tumor cells in vivo and in vitro","volume":"26","author":"Barbarese","year":"1995","journal-title":"J. Neurooncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"D\u2019Arrigo, J.S. (2019). Delaying dementia: Targeted brain delivery using lipid cubic phases. OBM Neurobiol., 3.","DOI":"10.21926\/obm.neurobiol.1903040"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"D\u2019Arrigo, J.S. (2018). Targeting early dementia: Using lipid cubic phase nanocarriers to cross the blood-brain barrier. Biomimetics, 3.","DOI":"10.20944\/preprints201802.0190.v1"},{"key":"ref_43","first-page":"19","article-title":"Treating dementia early: Limiting cellular damage in brain tissue","volume":"3","year":"2019","journal-title":"OBM Geriatr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1021\/la701206a","article-title":"Structural and rheological investigation of Fd3m inverse micellar cubic phases","volume":"23","author":"Pouzot","year":"2007","journal-title":"Langmuir"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1021\/la960664f","article-title":"An Fd3m lyotropic cubic phase in a binary glycolipid\/water system","volume":"12","author":"Seddon","year":"1996","journal-title":"Langmuir"},{"key":"ref_46","unstructured":"D\u2019Arrigo, J.S. (1987). Surfactant Mixtures, Stable Gas-in-liquid Emulsions, and Methods for the Production of such Emulsions from Said Mixtures. (4,684,479), U.S. Patent."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5498\/wjp.v6.i2.208","article-title":"Linking multiple pathogenic pathways in Alzheimer\u2019s disease","volume":"6","author":"Khoury","year":"2016","journal-title":"World J. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fnagi.2015.00119","article-title":"Oxidized cholesterol as the driving force behind the development of Alzheimer\u2019s disease","volume":"7","author":"Gamba","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/bph.12240","article-title":"Calcium channel blockers and dementia","volume":"169","author":"Nimmrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_50","first-page":"597","article-title":"The amyloid beta ion channel hypothesis of Alzheimer\u2019s disease","volume":"3","author":"Shirwany","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"28781","DOI":"10.1038\/srep28781","article-title":"Common molecular mechanism of amyloid pore formation by Alzheimer\u2019s \u03b2-amyloid peptide and \u03b1-synuclein","volume":"6","author":"Yahi","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1083\/jcb.201104133","article-title":"Single-channel Ca2+ imaging implicates A\u03b21-42 amyloid pores in Alzheimer\u2019s disease pathology","volume":"195","author":"Demuro","year":"2011","journal-title":"J. Cell. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1074\/jbc.M116.762526","article-title":"Ion channel formation by amyloid-\u03b242 oligomers but not amyloid-\u03b240 in cellular membranes","volume":"292","author":"Bode","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Polito, C.A., Cai, Z.U., Shi, Y.L., Li, X.M., Yang, R., Shi, M., Li, Q.S., Ma, S.C., Xiang, L.P., and Wang, K.R. (2018). Association of tea consumption with risk of Alzheimer\u2019s disease and anti-beta-amyloid effects of tea. Nutrients, 10.","DOI":"10.3390\/nu10050655"},{"key":"ref_55","unstructured":"Gambini, J. (2020). Oxidative stress and inflammation: From mechanisms to therapeutic approaches. Biomedicines, Available online: https:\/\/www.mdpi.com\/journal\/biomedicines\/special_issues\/oxidative_stress_inflammation_mechanisms_therapeutic."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3389\/fnins.2019.01444","article-title":"Interplay between mitochondrial oxidative disorders and proteostasis in Alzheimer\u2019s disease","volume":"13","author":"Alcain","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mad.2011.11.008","article-title":"Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer\u2019s disease","volume":"133","author":"Khalil","year":"2012","journal-title":"Mech. Ageing Dev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"20816","DOI":"10.1073\/pnas.1005888107","article-title":"Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model","volume":"107","author":"Thanopoulou","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnagi.2019.00290","article-title":"Systemic immune dyshomeostasis model and pathways in Alzheimer\u2019s disease","volume":"11","author":"Talwar","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fnagi.2019.00143","article-title":"The post-amyloid era in Alzheimer\u2019s disease: Trust your gut feeling","volume":"11","author":"Osorio","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1523\/JNEUROSCI.22-14-05900.2002","article-title":"Inflammation-dependent cerebral deposition of serum amyloid A protein in a mouse model of amyloidosis","volume":"22","author":"Guo","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_62","first-page":"25","article-title":"Modulation of inflammation in transgenic models of Alzheimer\u2019s disease","volume":"11","author":"Birch","year":"2014","journal-title":"J. Inflamm."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1074\/jbc.M405009200","article-title":"Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1\/2 and p38 mitogen-activated protein kinases","volume":"280","author":"Baranova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.2353\/ajpath.2010.090014","article-title":"A role for the high-density lipoprotein receptor SR-BI in synovial inflammation via serum amyloid-A","volume":"176","author":"Mullan","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1096\/fj.201600857RRR","article-title":"Serum amyloid A: An ozone-induced circulating factor with potentially important functions in the lung-brain axis","volume":"31","author":"Erickson","year":"2017","journal-title":"FASEB J."}],"container-title":["Biomimetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2313-7673\/5\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:10:01Z","timestamp":1760173801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2313-7673\/5\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["biomimetics5010011"],"URL":"https:\/\/doi.org\/10.3390\/biomimetics5010011","relation":{},"ISSN":["2313-7673"],"issn-type":[{"value":"2313-7673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}